Filing Flows › Cue Biopharma (CUE) › Q1 2026 › vs Q4 2025
Cue Biopharma (CUE) Q1 2026 vs Q4 2025 (quarter over quarter)
Cue Biopharma's revenue fell $16.3M (-74%) from $21.9M in Q4 2025 to $5.7M in Q1 2026.
Cue Biopharma, Q1 2026: revenue $5.7M (14× year over year), operating margin -94.1%, net loss $5.2M, operating cash flow −$10.9M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $5.7M | $21.9M | −$16.3M | -74% |
| Other income, net | $175K | −$393K | $568K | — |
| Net loss | $5.2M | −$1.6M | $6.8M | — |
| Costs & expenses | $11.0M | $21.9M | −$10.9M | -50% |
| Operating costs | $11.0M | $20.0M | −$8.9M | -45% |
| Research & development | $6.9M | $16.5M | −$9.6M | -58% |
| General & admin | $4.2M | $3.5M | $700K | +20% |
| Operating cash sources | $11.6M | $2.4M | $9.2M | +389% |
| Depreciation & amortization | $566K | $678K | −$112K | -17% |
| Share-based compensation | $48K | $610K | −$562K | -92% |
| Cash used in operations | $10.9M | $1.1M | $9.9M | +917% |
| Net loss absorbed | $5.2M | −$1.6M | $6.8M | — |
| Working capital & other | $6.4M | $3.9M | $2.4M | +62% |
Questions
How much did Cue Biopharma's revenue grow quarter over quarter in Q1 2026?
Cue Biopharma's revenue fell $16.3M (-74%) from $21.9M in Q4 2025 to $5.7M in Q1 2026.